Search
for
Sort by
Research 331–360 of 861
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- Targeted transfollicular delivery of artocarpin extract from Artocarpus incisus by means of microparticles
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- The Contribution of Endogenous and Exogenous Factors to Female Alopecia
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Androgenetic alopecia; drug safety and therapeutic strategies
- Female Adolescent Hair Disorders
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
- Novel inhibitors of 5α-reductase
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Assessment, diagnosis and treatment of a patient with hirsutism
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Mechanism of Salutary Effects of Finasteride on Post-traumatic Immune/Inflammatory Response
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Histological evaluation of follicular delivery of arginine via nanostructured lipid carriers: a novel potential approach for the treatment of alopecia
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy
- Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome